XML 19 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 6 Months Ended
Jul. 01, 2017
Jul. 02, 2016
Cash flows from operating activities:    
Net income $ 92,014 $ 57,600
Adjustments to reconcile net income to net cash (used in) provided by operating activities:    
Depreciation and amortization 9,462 8,132
Stock-based compensation 6,142 6,204
Gain (Loss) on Disposition of Property Plant Equipment 365 401
Deconsolidation, Gain (Loss), Amount 0 (273)
Provision for doubtful accounts (193) (51)
Changes in operating assets and liabilities:    
Increase in accounts receivable (2,094) (3,739)
Increase in inventories (15,554) (297)
Increase in deferred cost of goods sold (13,700) (1,566)
Increase (Decrease) in Other Noncurrent Assets (1,288) (6,596)
Increase (Decrease) in Other Current Assets (14,694) (7,462)
Increase in accounts payable 3,139 7,943
Decrease in accrued compensation (11,679) (3,937)
Decrease in accrued liabilities (67,641) (13,807)
Increase in deferred revenue 327 5,263
Increase in other non-current liabilities 985 3,875
Net cash (used in) provided by operating activities (14,409) 56,691
Deferred Income Tax Expense (Benefit) 0 5,001
Cash flows from investing activities:    
Purchases of property and equipment, net (8,512) (10,734)
Increase in intangible assets (1,574) (1,349)
Deconsolidation, Variable Interest Entity, Reduction of Cash 0 (763)
Net cash used in investing activities (10,086) (12,846)
Cash flows from financing activities:    
Proceeds from (Repayments of) Lines of Credit 0 45,000
Repayments of Lines of Credit 0 (55,000)
Payments of Debt Issuance Costs 0 (621)
Repayments of capital lease obligations (70) (69)
Proceeds from issuance of common stock 48,218 18,997
Repurchases of common stock 0 (68,218)
Net cash provided by (used in) financing activities 48,148 (59,911)
Effect of foreign currency exchange rates on cash 1,825 (196)
Net increase in cash and cash equivalents 25,478 (16,262)
Cash and cash equivalents at beginning of period 305,970 132,317
Cash and cash equivalents at end of period $ 331,448 $ 116,055